Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lung adenocarcinoma in the era of targeted therapies: histological classification, sample prioritization, and predictive biomarkers

Published:2013-01-29 Issue:7 Volume:15 Page:503-508
ISSN:1699-048X
Container-title:Clinical and Translational Oncology
language:en
Short-container-title:Clin Transl Oncol

Author:

Conde E.,Angulo B.,Izquierdo E.,Paz-Ares L.,Belda-Iniesta C.,Hidalgo M.,López-Ríos F.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12094-012-0983-z.pdf

Reference71 articles.

1. Travis WD, IASLC Staging Committee (2009) Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee. Histopathology 54:3–11

2. Edwards SL, Roberts C, McKean ME et al (2000) Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non small cell category. J Clin Pathol 53:537–540

3. Chuang MT, Marchevsky A, Teirstein AS et al (1984) Diagnosis of lung cancer by fibreoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas. Thorax 39:175–178

4. Thomas JS, Lamb D, Ashcroft T et al (1993) How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party. Thorax 48:1135–1139

5. Abratt RP, Lee JS, Han JY et al (2006) Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer. J Thorac Oncol 1:135–140

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Insights and Risk Factors Associated with Small and Non-small Cell Lung Cancer;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

2. Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement;Lung Cancer;2022-10

3. Consenso multidisciplinar para optimizar la determinación de alteraciones del gen NTRK;Revista Española de Patología;2021-10

4. Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma;Medicine;2021-09-03

5. Screening for ROS1 fusions in patients with advanced non-small cell lung carcinomas using the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody;Expert Review of Molecular Diagnostics;2021-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3